New Jersey 2022-2023 Regular Session

New Jersey Senate Bill S3668

Introduced

2/28/23

Refer

2/28/23

Caption

Establishes tianeptine as Schedule II controlled dangerous substance.

Latest NJ S3668 Activity

View All Events: NJ 2022-2023 Regular Session S3668

Companion Bills

No companion bills found.

Previously Filed As

NJ S322

Establishes tianeptine as Schedule II controlled dangerous substance.

NJ S1865

Adds illicit fentanyls to Schedule I in the "New Jersey Controlled Dangerous Substances Act."

NJ S2036

Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.

NJ A4494

Adds illicit fentanyls to Schedule I in the "New Jersey Controlled Dangerous Substances Act."

NJ SB946

Further providing for schedules of controlled substances and providing for tianeptine-related adverse health events.

NJ A864

Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.

NJ S2067

Increases penalty for crime of manufacturing, distributing, or dispensing certain Schedule I or II controlled dangerous substances.

NJ A3695

Increases penalty for crime of manufacturing, distributing, or dispensing certain Schedule I and II controlled dangerous substances.

NJ HB3767

Controlled dangerous substances; adding certain substances to Schedules I and IV; effective date.

NJ HB417

Criminal Law - Schedule III Controlled Dangerous Substances - Medetomidine and Xylazine

Similar Bills

NJ S322

Establishes tianeptine as Schedule II controlled dangerous substance.

Relating to adding certain substances to the Texas Controlled Substances Act and regulating kratom and kratom products; increasing civil penalties; creating criminal offenses; increasing a criminal penalty.

PA SB946

Further providing for schedules of controlled substances and providing for tianeptine-related adverse health events.

CA AB634

Tianeptine.

US HB3520

STAND Against Emerging Opioids Act Scheduling Tianeptine and Analogues Now to Defend Against Emerging Opioids Act

DE HB21

An Act To Amend Title 16 Of The Delaware Code Relating To Tianeptine.

NE LB475

Classify tianeptine as a controlled substance

SC H5485

Controlled Substances